Lactate dehydrogenase inhibitor alleviates LPS/D-Gal-induced acute liver injury in mice
- Author:
Xin-Yan ZAN
1
;
Meng-Xin YANG
1
;
Xin-Yue ZHANG
1
;
Yong-Qiang YANG
1
;
Li ZHANG
1
;
Xin-Yan ZAN
2
;
Meng-Xin YANG
2
;
Xin-Yue ZHANG
2
;
Yong-Qiang YANG
2
;
Li ZHANG
2
Author Information
- Publication Type:Journal Article
- Keywords: acute liver injury; glycolysis; inhibitor of lactate dehydrogenase; lactate; lactate dehydrogenase; lipopolysaccharide
- From: Chinese Pharmacological Bulletin 2023;39(2):299-304
- CountryChina
- Language:Chinese
- Abstract: Aim To investigate the effect of lactate dehydrogenase inhibitor on LPS/D-Gal-induced acute liver injury in mice. Methods BALB/ C mice were divided into four groups:solvent control group, lactate dehydrogenase inhibitor NHI-2 group, lipopolysaccharide(LPS)/ D-galactosamine(D-Gal)group and LPS/D-Gal+NHI-2 group. To induce acute liver injury, mice were injected intraperitoneally with LPS(10 μg·kg-1)and D-Gal(700 mg·kg-1), NHI-2 was intraperitoneally injected 30 min before LPS/D-Gal exposure. Liver tissue and serum were harvested 1.5 or 6 h after LPS/D-Gal exposure, serum lactate, serum aspartate aminotransferase(ALT), serum alanine aminotransferase(AST), serum tumor necrosis factor alpha(TNF-α)liver malondialdehyde(MDA)and liver caspase-3/8/9 levels were determined. HE staining was used to evaluate the degree of liver injury. TUNEL staining was used to evaluate hepatocyte apoptosis. Survival curve was used to record survival situation of tested mice. Results Serum lactate level of model mice was significantly reduced after treatment with NHI-2. Compared with LPS/D-Gal group, level of serum TNF-α showed no significant difference, but serum ALT and AST level of LPS/D-Gal+NHI-2 group significantly decreased, injury of liver structure was remarkably attenuated, level of MDA and activity of caspase-3/8/9 in liver were significantly down-regulated, and the number of TUNEL-positive cells was significantly reduced. Treatment with NHI-2 also significantly improved the survival rate of LPS/D-Gal-insulted mice. Conclusion Lactate dehydrogenase inhibitor alleviates LPS/D-Gal-induced acute liver injury in mice.
